Clinical Trials Sponsored by GCP-Copenhagen

Total 2126 results

Bjorn H. Ebdrup
Rigshospitalet, Denmark; ACADIA Pharmaceuticals Inc.; GCP unit, Copenhagen University...

Withdrawn

The Sub-Sero Study

Schizophrenia | Psychosis
Bo Feldt-Rasmussen
Novo Nordisk A/S; The GCP unit at Copenhagen University Hospital

Completed

Liraglutide Treatment to Patients With Severe Renal Insufficiency

Type 2 Diabetes Mellitus | End-stage Renal Disease

Denmark
Bo Feldt-Rasmussen
Novo Nordisk A/S; The GCP unit at Copenhagen University Hospital

Withdrawn

The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure (LiRA2)

Kidney Failure, Chronic | Prediabetic State

Denmark
Grete Andersen, MD
Region Capital Denmark; GCP-Copenhagen; Danish Region; Lupin Atlantis Holdings... and other collaborators

Recruiting

Treatment of Myotonia - Lamotrigine Versus Namuscla

Non-Dystrophic Myotonia

Denmark
University College Copenhagen
University of Copenhagen

Completed

Vitamin D and Calcium Supplementation at Danish Nursing Homes

Muscle Weakness | Frailty | Aging | Physical Disability

Denmark
Fundación GECP

Recruiting

Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy (MERIT-lung)

Non-small Cell Lung Cancer Stage III | KRAS P.G12C

Spain
Fundación GECP

Recruiting

Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases (NIVIPI-Brain)

Lung Cancer | Non Small Cell Lung Cancer | Brain Metastases, Adult

Spain
Fundación GECP

Recruiting

Study of the Efficacy and Safety of the Bintrafusp Alfa in Previously Treated Advanced Malignant Pleural Mesothelioma (BIMES)

Mesothelioma; Lung

Spain
Fundación GECP

Recruiting

Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients

Non Small Cell Lung Cancer | EGFR Gene Mutation

Spain
Fundación GECP

Active, not recruiting

Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients (CUBIK)

NSCLC | Lung Cancer | NSCLC Stage IV | NSCLC Stage IIIB

Spain
Fundación GECP

Active, not recruiting

New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy (NADIM-ADJUVANT)

Non-Small Cell Lung Cancer | Adjuvant Chemotherapy

Spain
Fundación GECP

Completed

Anti-SARS-COV2 Vaccination Study in Lung Cancer Patients (VAC-CaP)

Covid19 | Lung Cancer

Spain
Fundación GECP

Completed

Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positive (OSIREX)

Non Small Cell Lung Cancer

Spain
University Hospital, Gentofte, Copenhagen
University of Copenhagen; Steno Diabetes Center Copenhagen

Completed

The Effect of GIP(3-30)NH2 (GA-10)

Endocrine - Other

Denmark
Steno Diabetes Center Copenhagen
University of Copenhagen; University Hospital, Gentofte, Copenhagen

Completed

Liraglutide in Type 1 Diabetes

Diabetes Mellitus, Type 1 | Overweight

Denmark
Glostrup University Hospital, Copenhagen
University of Copenhagen; University Hospital, Gentofte, Copenhagen

Unknown

Antipsychotic Medicine and Metabolic Syndrome (AMMS1)

Metabolic Syndrome

Denmark
Fundación GECP

Completed

Characteristics of Sexual Dysfunction in Patients With Lung Cancer (LUDICAS)

Sexual Dysfunction | Lung Cancer

Spain, Portugal, Colombia, Argentina, Peru
Fundación GECP

Active, not recruiting

NADIM II: Neo-Adjuvant Immunotherapy (NADIMII)

Non Small Cell Lung Cancer

Spain
Fundación GECP

Completed

Spanish Real World Data on Patients Treated With Durvalumab After Chemoradiotherapy. (S-REAL)

Small Cell Lung Cancer (SCLC)

Spain
Fundación GECP

Completed

Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection (SOLID)

Lung Cancer | COVID | Corona Virus Infection

Spain
GMP Endotherapeutics

Completed

Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States
Copenhagen University Hospital, Hvidovre
University of Copenhagen

Recruiting

Amantadine for COVID-19 (ACT)

Covid19

Denmark
Copenhagen University Hospital, Hvidovre
University of Copenhagen

Recruiting

A Pathophysiological Study of the Postprandial Human Liver (PLS) (PLS)

Fatty Liver | Cirrhosis

Denmark
University of Copenhagen
Copenhagen University Hospital, Denmark

Completed

Interaction Between Immune Cells and Bacteria Associated With Periodontitis

Inflammation | Rheumatoid Arthritis | Periodontitis | Periodontal Diseases | Dysbiosis | Aggressive Periodontitis | Chronic Periodontitis | Periodontal Pocket | Generalized Chronic Periodontitis | Microbial Disease | Inflammation Gum | Immunologic Disease | Generalized Aggressive Periodontitis

Denmark
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Completed

Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4)

Glucose Metabolism Disorders

Denmark
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Completed

The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2D

Glucose Metabolism Disorders

Denmark
University of Copenhagen
Copenhagen University Hospital, Denmark

Completed

An Investigation of General Predictors for CBT Outcome for Anxiety Disorders in a Naturalistic Setting

Anxiety Disorders

Denmark
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Completed

Inhibition of the Endogenous GIP Response With a GIP Receptor Antagonist (GA-3)

Glucose Metabolism Disorders

Denmark
University of Copenhagen
University Hospital, Gentofte, Copenhagen

Completed

Frequent Ballgames Training for 9-11 Year Old Schoolchildren

Body Composition | Echocardiography

Denmark
Glostrup University Hospital, Copenhagen
University of Copenhagen

Completed

-Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans.

Type 2 Diabetes

Denmark
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Unknown

Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) Effects

Vagotomy, Truncal

Denmark
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Unknown

Intact Vagal Innervation and Glucagon-like Peptide-1 (GLP-1) Effects

Vagotomy, Truncal

Denmark
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Completed

The Incretin Effect in Patients With Chronic Pancreatitis

Type 2 Diabetes Mellitus | Chronic Pancreatitis

Denmark
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Completed

Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM)

Hyperglycemia | Glucose Intolerance | Hyperglucagonemia
University Hospital, Gentofte, Copenhagen
University of Copenhagen; Steno Diabetes Center Copenhagen

Completed

Pathophysiological Implications of the Incretin Hormones in Maturity Onset of Diabetes of the Young (MODY)

Maturity-onset Diabetes of the Young

Denmark
GCS CIPS

Not yet recruiting

Correlates of Fatigue in People With Schizophrenia (FIZO-2)

Schizophrenia
Fundación GECP

Recruiting

DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors (DUMAS)

NSCLC | Pancoast Tumor

Spain
Fundación GECP

Recruiting

Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer (PEERS)

Small Cell Lung Cancer Extensive Stage

Spain
Fundación GECP

Recruiting

Study of ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC Patients Treated With Neoadjuvant Treatment (REAL-NADIM)

Neoadjuvant Treatment | Non Small Cell Lung Cancer Stage III

Spain
Fundación GECP

Recruiting

Pathological Response After Neoadjuvant Treatment on NSCLC (PLANET)

Stage IIIA Non-small Cell Lung Cancer

Spain
Fundación GECP

Recruiting

Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) (APOLO)

Lung Diseases | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Thoracic Neoplasms | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Carcinoma Bronchiogenic Stage III

Spain
Fundación GECP

Active, not recruiting

Atezolizumab Plus Bevacizumab in First Line NSCLC Patients (TELMA)

Non Small Cell Lung Cancer

Spain
Fundación GECP

Completed

Efficacy & Safety Study of Lorlatinib in ALK/ROS1 Metastatic NSCLC Patients With Compassionate Use Treatment (LORLAPULM)

Metastatic Non Small Cell Lung Cancer

Spain
SCP Battistelli

Completed

Alcohol Abuse or Alcohol Withdrawal: Risk of Latent Scurvy

Alcoholics
Copenhagen University Hospital, Hvidovre
Copenhagen University Hospital Bispebjerg-Frederiksberg; Copenhagen University... and other collaborators

Recruiting

Rethinking Pulmonary Rehabilitation (REPORT)

Chronic Obstructive Pulmonary Disease

Denmark
Copenhagen University Hospital, Hvidovre
University of Copenhagen

Not yet recruiting

Virus as Treatment of C. Difficile Infection (VISION) (VISION)

Clostridium Difficile Infections

Denmark
Steno Diabetes Center Copenhagen
University of Copenhagen

Recruiting

Healthy Lifestyle Before and During Pregnancy to Prevent Childhood Obesity - the PRE-STORK-trial

Pregnancy Related | Overweight and Obesity

Denmark
Copenhagen University Hospital, Hvidovre
University of Copenhagen

Recruiting

Family Centred Healthcare - Zero Separation and Couplet Care

Premature Birth | Infant | Mother-Child Relations | Post Partum | Family

Denmark
Copenhagen University Hospital, Hvidovre
University of Copenhagen

Recruiting

Prospective Cohort Study of Disease and Outcomes in Cirrhosis (ProDoc)

Liver Diseases | Decompensated Cirrhosis | Progression | Liver Cirrhosis, Alcoholic

Denmark
University of Copenhagen
Copenhagen University Hospital, Hvidovre

Recruiting

Co-infusion of Neurotensin and GLP-1 Effects on Appetite and Food Intake.

Obesity

Denmark

Clinical Trials Sponsored by GCP-Copenhagen

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations